2,3-Difluoro-4-methylbenzoic acid, 97.0%, 5g

6H-indolo[2,3-b]quinoxaline, 5g

2-(Pyrrolidin-1-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

2',5'-Dimethyl-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde, 97%, 2.5g

ROTI®Cell 10x PBS

4-(2,4-dioxoimidazolidin-1-yl)benzoic acid, 95.0%, 25g

2,4-Dibromobenzaldehyde, 95.0%, 250mg

2-Amino-n,4-dimethylpentanamide hydrochloride, 95%, 1g

2-Methylsuccinic acid, 95.0%, 100g

2-(3-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 25g

3-sec-butoxybenzaldehyde, 95.0%, 5g

2-Chloro-3,5-diiodopyridine, 95.0%, 250mg

N,N'-Methylenebismethacrylamide>96.0%(T)25g